Development of a Digital Tool for the Individualization of Speech Therapy Care for Premature Newborns
NCT ID: NCT05992181
Last Updated: 2024-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2023-09-15
2024-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interdisciplinary E-health Based Follow-up of Preterm Born Children
NCT06345664
Comparison of Two Early Treatments for Premature Babies and Their Effects Over Time
NCT07261046
Listening to Mom 2: Neural, Clinical and Language Outcomes
NCT04193579
Non-invasive Ventilation in Preterm Infants
NCT05987800
Psychomotor Therapy for Very Premature Infants
NCT03093337
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group A - control: receiving the speech therapy currently in place in the department.
Group B - experimental: will receive the same care as the first group, plus access to the videos and the introduction of early orofacial stimulation.
Group B: First, an initial assessment will be performed in speech-language pathology of the oro-myofunctional and oral functions of the newborn. This will determine which orofacial solicitations to give to the baby and create in the patient's profile.
Parents will be trained in orofacial stimulation and will be coached during the first sessions. When parents are ready, access will be given to their personal space on the application. Appointments will be scheduled to remodel the treatment if necessary. Sucking (ECEPAB), feeding (PIBBS) and behavioural (EDIN) abilities will be assessed. Parents will be asked to fill out a questionnaire about their feelings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
With the speech therapy already in place in the department.
No interventions assigned to this group
experimental group
With the speech therapy already in place in the department, plus access to videos and the introduction of early orofacial stimulation.
NEORTHO
early orofacial stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NEORTHO
early orofacial stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Alive for minimum 24h.
* Holders of parental authority who have been informed of the study and have not objected.
Exclusion Criteria
* with a genetic or severe neurological pathology or withdrawal syndrome.
* with a vital prognosis.
* whose family home is too far from the service.
24 Hours
3 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Sud Francilien
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01290-45
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.